申请人:Sanofi-Synthelabo
公开号:US06143761A1
公开(公告)日:2000-11-07
Compounds corresponding to the general formula (I) ##STR1## in which R.sub.1 represents a hydrogen atom, a (C.sub.1 -C.sub.6)alkyl group or a phenyl(C.sub.1 -C.sub.4)alkyl group, R.sub.2 represents a hydrogen atom or a (C.sub.1 -C.sub.6)alkyl group and R.sub.3, R.sub.4 and R.sub.5 each represent, independently of one another, a hydrogen or halogen atom or a trifluoromethyl, cyano, hydroxyl, (C.sub.1 -C.sub.6)alkyl or (C.sub.1 -C.sub.6)alkoxy group. Application in therapeutics.
符合一般公式(I)的化合物##STR1##中,其中R.sub.1代表氢原子,(C.sub.1 -C.sub.6)烷基或苯基(C.sub.1 -C.sub.4)烷基,R.sub.2代表氢原子或(C.sub.1 -C.sub.6)烷基,R.sub.3、R.sub.4和R.sub.5各自独立地代表氢或卤素原子,或三氟甲基、氰基、羟基、(C.sub.1 -C.sub.6)烷基或(C.sub.1 -C.sub.6)烷氧基。在治疗学中的应用。